|
High $0.00 |
Low $0.00 |
Trades 3 |
Turnover $1,511 |
Volume 672,333 |
| 30 June 2023 at 1:49pm | ||||
|
Market Cap (4-Jul) $5,671,263 (1,275th) |
Close (30-Jun) $0.003 |
Volume (30-Jun) 672,333 |
Shortsold (23-Mar) 355,000 (0.00%) (603rd) |
|
52w High $0.077 |
52w Low $0.036 |
P/E - |
EPS 0 |
GTG released this announcement to the ASX on 25 February 2022, 9:44. The announcement is not marked as price sensitive, and is 34 page(s) in length and 3.1MB in size.
You can view all announcements from GTG and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from GTG | |
|---|---|
| Notification of cessation of securities - GTG | 10 May 2023, 13:54 |
| Updated Investor Presentation and Investor Webinar | 2 May 2023, 8:59 |
| Publication Validates geneType for Melanoma Risk Assessment | 28 April 2023, 9:02 |
| GeneType Half Year Update Presentation | 25 February 2022, 9:44 |
| Genetic Technologies 1H FY22 results | 24 February 2022, 9:33 |
| Half Year Report and Accounts | 24 February 2022, 9:31 |
| US Patent Office Grants Patent for COVID-19 Risk Test | 23 February 2022, 17:13 |
You must be logged in to post a reply.
Genetic Technologies 